This federal contract award, valued at $7,873.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,566,340,622 units of Ondansetron HCL 4 mg tablets, with a firm fixed price and an ultimate completion date of November 6, 2024.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular award is not designated with any set-aside requirements, indicating open competition. The contract aligns with the DLA's role in supplying essential medical commodities, including specialty medications, vaccines, and other critical healthcare products, to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 2/4/25, 10:40 AM